ID

TEN, Ltd. Announces Date of Fourth Quarter and Year End 2023 Results, Conference Call and Webcast

Retrieved on: 
Thursday, March 21, 2024
International, ID, Webcast, TNP, LNG, Broadcasting

The call, which will be hosted by TEN's senior management, may contain information beyond that which is included in the earnings press release.

Key Points: 
  • The call, which will be hosted by TEN's senior management, may contain information beyond that which is included in the earnings press release.
  • Alternatively, participants can register for the call using the call me option for a faster connection to join the conference call.
  • Simultaneous Slides and Audio Webcast:
    There will also be a live, and then archived, webcast of the conference call and accompanying slides, available through the Company’s website.
  • Participants to the live webcast should register on the website approximately 10 minutes prior to the start of the webcast.

Dynagas LNG Partners LP Announces Date for the Release of the Fourth Quarter 2023 Results, Conference Call and Webcast

Retrieved on: 
Thursday, March 21, 2024
Webcast, International, ID, LNG, PDF, QWERTY, Broadcasting

The same day, Thursday, March 28, 2024, at 10:00 a.m. Eastern Time, the Company's management will host a conference call and webcast to discuss the earnings results.

Key Points: 
  • The same day, Thursday, March 28, 2024, at 10:00 a.m. Eastern Time, the Company's management will host a conference call and webcast to discuss the earnings results.
  • Audio Webcast - Slides Presentation:
    There will be a live and then archived webcast of the conference call and accompanying slides, available on the Company’s website.
  • To listen to the archived audio file, visit our website http://www.dynagaspartners.com and click on Webcast under our Investor Relations page.
  • Participants to the live webcast should register on the website approximately 10 minutes prior to the start of the webcast.

X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 21, 2024
Security (finance), WHIM, WHIM syndrome, Conference call, Conference, RPD, New Drug Application, Ageing, Orphan, Wart, NDA, Priority review, Research and development, Immune system, File, ID, FDA, X4, PDUFA, Pharmaceutical industry

BOSTON, March 21, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted key 2023 events and expected upcoming milestones.

Key Points: 
  • “Following an incredibly productive 2023, we are expecting a transformative year in 2024,” said Paula Ragan, Ph.D., President and Chief Executive Officer of X4 Pharmaceuticals.
  • X4 will host a conference call and webcast today at 8:30 am ET to discuss these financial results and business highlights.
  • The live webcast can be accessed on the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com .
  • Following the completion of the call, a webcast replay of the conference call will be available on the company website.

Dax Hayden Recognized as the 2023 RLI APEX National Broker of the Year in Ag Land Ranch Sales

Retrieved on: 
Thursday, March 21, 2024
Land, Conference, RLI, Herrity, The Land Institute, The Land Report, RCE, APEX, MBA, CO, Dax, ID, Marketing, Advertising, Real estate

Windsor, CO, March 21, 2024 (GLOBE NEWSWIRE) -- Dax Hayden, with Hayden Outdoors Real Estate in Windsor, CO, has been recognized as the APEX 2023 National Broker of the Year in Ag Land Ranch Sales by the REALTORS® Land Institute as a part of the RLI APEX Production Awards Program, sponsored by The Land Report.

Key Points: 
  • Windsor, CO, March 21, 2024 (GLOBE NEWSWIRE) -- Dax Hayden, with Hayden Outdoors Real Estate in Windsor, CO, has been recognized as the APEX 2023 National Broker of the Year in Ag Land Ranch Sales by the REALTORS® Land Institute as a part of the RLI APEX Production Awards Program, sponsored by The Land Report.
  • This is the 2nd year in a row the Kansas native has outsold the country in Ranch land sales.
  • Dax is joined by many other agents within Hayden Outdoors Real Estate that have sold a tremendous amount of land in 2023.
  • Forty two agents and brokers had sold over $5 Million in land sales within the brokerage in 2023, helping the brokerage to over $1 Billion in land sales in 2023 and over $5 Billion since 2019.

Tatari makes significant updates and improvements to its TV ad measurement

Retrieved on: 
Thursday, March 21, 2024
Hundred, ID, SAN, Privacy, Meta, Algorithm, IP, Acquisition, Advertising, CPA, Video game

This update mostly focuses on improvements to Tatari’s device graph data through internal enhancements and strategic partnerships, paving the way for the most accurate TV ad measurement available to brands and agencies.

Key Points: 
  • This update mostly focuses on improvements to Tatari’s device graph data through internal enhancements and strategic partnerships, paving the way for the most accurate TV ad measurement available to brands and agencies.
  • Significant changes include:
    Linking multiple devices within a household helps determine which viewer is taking an action (e.g.
  • “Similar to how Google and Meta constantly enhance their algorithms, Tatari is dedicated to continuous innovation for measuring TV ad campaigns,” said Mike Swinson, Chief Data Scientist of Tatari.
  • “As more advertisers seek to measure their TV campaigns on outcomes (visits, purchases, installs, etc), our view-through and incremental measurement methodologies must evolve.”
    Hundreds of brands and agencies use the Tatari platform to buy, measure, and optimize TV ad campaigns that drive real business outcomes.

authID Inc. Reports Financial and Operating Results for the Fiscal Year Ended December 31, 2023

Retrieved on: 
Wednesday, March 20, 2024
Momentum, Conference, Growth, RPO, ISMS, Webcast, Patient, Information, EDT, News, Fintech, Certification, ABM Industries, Zoom, Fortune 500, Confidentiality, Workforce, ID, Digital technology, Calendar, ABM, Fiscal, Engineering

DENVER, March 20, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of innovative biometric identity verification and authentication solutions, today reported financial and operating results for the full year ended December 31, 2023.

Key Points: 
  • The reduction was primarily attributed to revenue from a legacy authentication product that was discontinued in April 2022.
  • Operating expenses for the twelve-month period in 2023 declined by 52% to $10.9 million, compared with $22.8 million for 2022.
  • Adjusted EBITDA loss (Non-GAAP, as defined below) for Fiscal Year 2023 improved to $8.7 million, compared with $11.4 million, for 2022.
  • The Company will host a webcast today at 5:30 p.m. EDT to discuss the financial results and provide a corporate update.

Avatier Unveils Patent-Pending Enterprise Self-Service Password Reset (SSPR) to Prevent Catastrophic Data Breaches

Retrieved on: 
Wednesday, March 20, 2024
Microsoft, PIN, Government, MFA, ServiceNow, RACF, Internet, PIV, SAP, IBM, SSPR, Paramount, SSO, Workforce, PeopleSoft, ID, Patent, Kansas City Chiefs, IGA, Online shopping

In an era where data security is paramount, Avatier's commitment to excellence takes a leap forward, offering a game-changing 2024 Enterprise Self-Service Password Reset (SSPR) solution.

Key Points: 
  • In an era where data security is paramount, Avatier's commitment to excellence takes a leap forward, offering a game-changing 2024 Enterprise Self-Service Password Reset (SSPR) solution.
  • With no enrollment needed for most major MFA providers, Avatier enhances your current password management solution, offering assisted password reset with verification as an essential security layer.
  • Why don’t we use the same method for both?”
    To address enterprise self-service password management challenges, Avatier emphasizes many user enrollment options and widespread convenient usability.
  • The Avatier Password Management solution, when implemented alongside existing password reset systems, offers unparalleled flexibility with multiple enrollment options.

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Retrieved on: 
Tuesday, March 19, 2024
Diary, Patient, IND, Adolescence, Pediatrics, Therapy, FAAP, Rett syndrome, Research, Central nervous system, Risk, Webcast, CNS, Ageing, CHU, Safety, AAV, Mutation, Development, MECP2, Disease, Associate, Sleep, Șaeș, Dysrhythmia, FRCP, MTD, Movement, IDMC, VG, Hyperventilation, Principal, Administration, Index, Seizure, CTA, Female, MHRA, Phenotype, ID, Frasier, Pharmaceutical industry

Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.

Key Points: 
  • Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.
  • Dr. Schultz is a board-certified, licensed pediatric neurologist experienced in treating patients with Rett syndrome and leading gene therapy clinical trials.
  • She brings more than 17 years of clinical experience and will lead the Company’s clinical development, clinical operations, medical affairs and safety activities.
  • ET to review its financial and operating results and to provide corporate and clinical updates.

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients

Retrieved on: 
Tuesday, March 19, 2024
Arthralgia, Abdominal pain, Acromegaly, Headache, Webcast, Patient, Diarrhea, NDA, FISU World University Games, ID, Endocrinology, Food, Medical school, Pharmaceutical industry

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, today announced positive topline results from PATHFNDR-2, the second of two Phase 3 studies evaluating the efficacy and safety of oral, once-daily investigational paltusotine for the treatment of acromegaly.

Key Points: 
  • “This study demonstrates that paltusotine can provide both symptom control as well as biochemical control in patients who are not currently on pharmacologic treatment.
  • The frequency of participants with at least one treatment emergent adverse event (TEAE) was comparable in the paltusotine treatment arm and placebo arm.
  • The frequency of adverse events considered related to acromegaly was notably lower in paltusotine treated participants compared to placebo treated participants.
  • Following the live event, a replay will be available on the Investors section of the Company’s website.

LKQ Corporation to Release First Quarter 2024 Results on Tuesday, April 23, 2024

Retrieved on: 
Tuesday, March 19, 2024
International, Webcast, ID, LKQ Corporation, LKQ

CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its first quarter 2024 financial results on Tuesday, April 23, 2024.

Key Points: 
  • CHICAGO, March 19, 2024 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its first quarter 2024 financial results on Tuesday, April 23, 2024.
  • LKQ will host a conference call and webcast on April 23, 2024 at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) with members of senior management to discuss the Company's results.
  • To access the investor conference call, please dial (833) 470-1428. International access to the call may be obtained by dialing (404) 975-4839.
  • The investor conference call will require you to enter conference ID: 568620.